Paromomycin (CAS 7542-37-2), C23H45N5O14, the formula weight is 615.63.
Paromomycin has a strong killing effect on amoeba, and has good antibacterial activity against Gram-negative bacilli and acid-fast bacilli.

Market Analysis and Insights: Global and United States Paromomycin (CAS 7542-37-2) Market
This report focuses on global and United States Paromomycin (CAS 7542-37-2) market.
In 2020, the global Paromomycin (CAS 7542-37-2) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Paromomycin (CAS 7542-37-2) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Paromomycin (CAS 7542-37-2) Scope and Market Size
Paromomycin (CAS 7542-37-2) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Paromomycin (CAS 7542-37-2) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Paromomycin (CAS 7542-37-2) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
95% Purity Type
96% Purity Type
Others

Segment by Application
Paromomycin Sulfate
Paromomycin Injection

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pfizer
Kaifeng Pharm
Shanhe Pharm
Changrui Pharm
ERFA Canada